November 2020

Washington Post Perspective: "The secret weapon for distributing a potential covid-19 vaccine" by Joanna Radin

On Monday, the pharmaceutical company Pfizer announced early data that showed a vaccine it has been developing in partnership with the German drug manufacturer BioNTech was more than 90 percent effective in preventing covid-19. This level of efficacy amazed researchers, including those at my own institution, Yale School of Medicine, who agreed that if the data holds (it has not yet been peer reviewed), then this vaccine would be poised to dramatically curtail the impact of the virus.